Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.
Press releases published on October 9, 2025
Anortech Expands High-Purity Anorthosite Footprint At Gronne Bjerg Project In Greenland
VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- ANORTECH INC. (“AnorTech” or the “Company”) (TSX Venture Exchange “ANOR”; OTC “ANORF”) is pleased to announce exceptional results of the 2025 field program on the Gronne Bjerg Anorthosite …
Verde AgriTech Commences Drilling at District Scale Clay Hosted Rare Earths Discovery in Minas Gerais, Brazil
Second rig arriving at site in two days; third rig mobilizing in ~15 days Near term focus is defining initial high-quality resources for the fastest viable path to production SINGAPORE, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd. (TSX: NPK | …
Imperial Ginseng Provides Further Update on Transaction with One Bullion
VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Imperial Ginseng Products Ltd. (TSXV: IGP) (the “Company”), further to its news releases on May 8 and August 14, 2025, provides a further update with respect to its previously announced reverse …
ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Positioned to Deliver Scale, Upside in Attractive Mining Equities Space
NEW YORK , Oct. 09, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN ( …
RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD
LOS ALTOS, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug-delivery …
DPM Metals Announces Preliminary Third Quarter Production Results and Timing of Third Quarter Financial Results
TORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or “the Company”) announced preliminary production results for the three and nine months ended September 30, 2025. “The integration of Vareš into our …
Milestone® Pharmaceuticals to Present Data on Etripamil at the American Heart Association Scientific Sessions 2025
MONTREAL and CHARLOTTE, N.C., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will …
Introducing the Beghou Arc™ Platform, Helping Life Sciences Companies Adapt Faster, Execute with Precision, and Drive Stakeholder Trust
EVANSTON, Ill., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Beghou announces the Beghou Arc Platform, a flexible, connected commercialization platform designed to help life sciences teams overcome data overload, rigid, one-size-fits all systems, and low stakeholder …
HI-VIEW DEFINES NEW PORPHYRY TARGET AND STRUCTURALLY CONTROLLED PRECIOUS METAL TARGETS IN CLOSE PROXIMITY TO AURORA
VANCOUVER, BRITISH COLUMBIA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- HI-VIEW RESOURCES INC. (“Hi-View” or the “Company”) (CSE: HVW; OTCQB: HVWRF; FSE: B63) announces the results from its 2025 soil and rock sampling program on the Lawyers East Block, part of its …
Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit
Presentation to provide comprehensive overview of AVIM Therapy clinical evidence demonstrating the potential to halt the progression of hypertensive heart disease Orchestra BioMed and Medtronic (NYSE: MDT) have a strategic collaboration to develop and …
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets
BOSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing antibody-drug conjugate (ADC) therapeutics for difficult-to-treat cancers, today announced the appointment of Alex Kane, MBA, as Senior Vice …
CanAlaska Announces Up to C$15 Million “Best Efforts” Private Placement
Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- CanAlaska Uranium Ltd. (TSX-V: CVV; OTCQX: CVVUF; Frankfurt: DH7) (“CanAlaska” or the “Company …
Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients
Second-generation delivery device offers cost-effective alternative to hospital care benefiting patients, providers, and payors Lasix ONYU is the 17th Captisol-enabled™ approved product JUPITER, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Ligand …
Azimut confirme une découverte de surface à haute teneur en lithium sur la Propriété Wabamisk Est, région de la Baie James, Québec
LONGUEUIL, Québec, 09 oct. 2025 (GLOBE NEWSWIRE) -- Exploration Azimut Inc. (« Azimut » ou la « Société ») (TSXV : AZM) (OTCQX : AZMTF) annonce des résultats positifs suite au programme de terrain systématique de cet été sur sa Propriété Wabamisk Est (la …
Azimut Confirms Extensive High-Grade Lithium Surface Discovery on Wabamisk East Property, James Bay Region, Quebec
LONGUEUIL, Quebec, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) is pleased to announce positive results from a systematic field program conducted this summer on its Wabamisk East Property …
Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer
VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …
MEXC Concludes "Race to Zero" Event, Unlocking 1 BTC Prize Pool
VICTORIA, Seychelles, Oct. 09, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, has successfully concluded its "Race to Zero" event, attracting 134,349 registered users and unlocking a 1 BTC prize pool (valued at 122,194.64 USDT), …
Italfarmaco Appoints Francesco Di Marco as Chief Executive Officer
MILAN, Italy, October 09, 2025 – Italfarmaco S.p.A. today announced that Dr. Francesco Di Marco has been appointed as Chief Executive Officer (CEO), effective January 1, 2026. Dr. Di Marco brings over 25 years of experience in the biopharmaceutical …
Volcan Compañía Minera S.A.A. Offer to Purchase for Cash Any and All of its Outstanding 8.750% Senior Secured Notes due 2030 and Consent Solicitation
LIMA, Peru, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Volcan Compañía Minera S.A.A. (“Volcan”), a publicly held corporation (sociedad anónima abierta) organized under the laws of the Republic of Peru with its principal executive office at Av. Manuel Olguín 373, …